However, while treatment with macrophage-depleting drugs, such as colony-stimulating factor 1 receptor (CSF1R) inhibitors and clodronate, or with CCR2-CCL2 pathway inhibitors to attenuate macrophage migration, can reduce macrophage tumor infiltration 43, these approaches may not be ideal as disease therapies. The gene discussed is CSF1R; the disease is neoplasm.